MaxCyte Sees $30M–$32M Revenue Target for 2026: MaxCyte targets $30M–$32M revenue for 2026, citing ExPERT DTx launch and SPL milestones (Seeking Alpha, Mar 25, 2026); execution and milestone timing are decisive. 👈 Read full analysis #MaxCyte #RevenueTarget #ExPERTDTx #SPLMilestones #FinancialGoals
MaxCyte Sees $30M–$32M Revenue Target for 2026
MaxCyte targets $30M–$32M revenue for 2026, citing ExPERT DTx launch and SPL milestones (Seeking Alpha, Mar 25, 2026); execution and milestone timing are decisive.
dlvr.it
March 25, 2026 at 6:32 AM
MaxCyte Sees $30M–$32M Revenue Target for 2026: MaxCyte targets $30M–$32M revenue for 2026, citing ExPERT DTx launch and SPL milestones (Seeking Alpha, Mar 25, 2026); execution and milestone timing are decisive. 👈 Read full analysis #MaxCyte #RevenueTarget #ExPERTDTx #SPLMilestones #FinancialGoals